Global Zika Virus Testing Market is anticipated to grow with a healthy growth rate of more than 2.5 % over the forecast period 2021-2027.

Global Zika Virus Testing Market Size study, by Test Type (Rapid IgG/IgM Test, ELISA Test) by End-User (Hospitals & Clinics, Private Commercial Laboratories, Government/Publicly Funded Programs) and Regional Forecasts 2021-2027
Product Code:  HALB_78350427
Chapter 1.Executive Summary 
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Zika Virus Testing Market, by Region, 2019-2027 (USD Billion)
1.2.2. Zika Virus Testing Market, by Test Type, 2019-2027 (USD Billion)
1.2.3. Zika Virus Testing Market, by End-User, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Zika Virus Testing Market Definition and Scope 
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Zika Virus Testing Market Dynamics 
3.1. Zika Virus Testing Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Government initiatives to develop innovative tests capable of detecting the Zika virus
3.1.1.2. Massive awareness campaigns
3.1.2. Market Challenges
3.1.2.1. Inefficiency of these tests in delivering results
3.1.3. Market Opportunities
3.1.3.1. Introduction of highly advanced testing mechanisms
Chapter 4. Global Zika Virus Testing Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political 
4.2.2. Economical
4.2.3. Social 
4.2.4. Technological 
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Zika Virus Testing Market, by Test Type 
5.1. Market Snapshot 
5.2. Global Zika Virus Testing Market by Test Type, Performance - Potential Analysis
5.3. Global Zika Virus Testing Market Estimates & Forecasts by Test Type 2018-2027 (USD Billion)
5.4. Zika Virus Testing Market, Sub Segment Analysis
5.4.1.  Rapid IgG/IgM Test
5.4.2. ELISA Test
Chapter 6. Global Zika Virus Testing Market, by End-User          
6.1. Market Snapshot 
6.2. Global Zika Virus Testing Market by End-User, Performance - Potential Analysis
6.3. Global Zika Virus Testing Market Estimates & Forecasts by End-User 2018-2027 (USD Billion)
6.4. Zika Virus Testing Market, Sub Segment Analysis
6.4.1.  Hospitals & Clinics
6.4.2. Private Commercial Laboratories
6.4.3. Government/Publicly Funded Programs
Chapter 7. Global Zika Virus Testing Market, Regional Analysis
7.1. Zika Virus Testing Market, Regional Market Snapshot 
7.2. North America Zika Virus Testing Market 
7.2.1. U.S. Zika Virus Testing Market
7.2.1.1.  Test Type breakdown estimates & forecasts, 2018-2027 
7.2.1.2.  End-User breakdown estimates & forecasts, 2018-2027 
7.2.2. Canada Zika Virus Testing Market
7.3. Europe Zika Virus Testing Market Snapshot
7.3.1. U.K. Zika Virus Testing Market 
7.3.2. Germany Zika Virus Testing Market
7.3.3. France Zika Virus Testing Market
7.3.4. Spain Zika Virus Testing Market
7.3.5. Italy Zika Virus Testing Market
7.3.6. Rest of Europe Zika Virus Testing Market
7.4. Asia-Pacific Zika Virus Testing Market Snapshot
7.4.1. China Zika Virus Testing Market 
7.4.2. India Zika Virus Testing Market 
7.4.3. Japan Zika Virus Testing Market
7.4.4. Australia Zika Virus Testing Market
7.4.5. South Korea Zika Virus Testing Market
7.4.6. Rest of Asia Pacific Zika Virus Testing Market
7.5. Latin America Zika Virus Testing Market Snapshot
7.5.1. Brazil Zika Virus Testing Market
7.5.2. Mexico Zika Virus Testing Market
7.6. Rest of The World Zika Virus Testing Market

Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1.  EUROIMMUN US Inc.
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2.   Creative Diagnostics
8.2.3. Quest Diagnostics
8.2.4. Artron Laboratories Inc.
8.2.5. RapiGEN Inc.
8.2.6. GenBody Inc.
8.2.7. JAJ International Inc.
8.2.8. LumiQuick Diagnostics Inc.
8.2.9. Biocan Diagnostics Inc.
8.2.10. NECTAR LIFESCIENCES LTD.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

Global Zika Virus Testing Market is valued approximately USD XX million in 2020 and is anticipated to grow with a healthy growth rate of more than 2.5 % over the forecast period 2021-2027. Zika is a flavivirus that is spread by Ades mosquitos and causes a disease. It may also be passed from person to person by sexual intercourse or from the mother to the foetus during pregnancy. Headache, nausea, fatigue, fever, and rash are all symptoms of the illness. For the time being, there is no cure for the Zika virus outbreak. To relieve the symptoms, only palliative treatment is available. The Zika virus testing kits that are currently on the market are observational tests that detect Zika virus RNA in body samples including urine, plasma, and serum. Immunoglobulin M (IgM) antibodies are shown to grow against Zika virus a few days after infection. To prove the existence of the Zika virus testing in the human body, the RNA identification test and the positive serum test for IgM are used. Leading players in the industry have increased their research and development efforts in response to government measures to create novel tests capable of reliably detecting the Zika virus. To stop the epidemic from spreading, the government launched huge public information drives, which increased the pace of infection diagnostics and monitoring. As the severity of the outbreak has decreased, so has the number of people who have been tested. Government and structural attempts, on the other hand, are never-ending in their pursuit of potential breakthroughs. Furthermore, the current COVID-19 pandemic has encouraged people to test for the prevalence of viral strains as a precautionary measure, which has boosted growth potential. The zika virus has a high chance of being spread from a pregnant woman to her foetus, according to documented studies. Microcephaly and other serious foetal brain abnormalities are caused by infection during birth. It can can trigger neurodevelopmental abnormalities such as hearing and vision loss, reduced locomotion, epilepsy, and other problems. As a result, it is now mandatory for women to be tested for the prevalence of the virus in their bloodstream on a regular basis. Fortunately, various technical advances have allowed the global healthcare industry to evolve successful virology diagnosis and treatment methods, resulting in the development of extremely sophisticated research frameworks. Viral culture, antigen identification, nucleic acid detection, and serology are among the methods used. The central arsenal of procedures used for laboratory diagnosis of various viral infections includes viral isolation and a variety of approaches for detecting viral antigens, nucleic acids, and antibodies. However, inefficiency of these tests in delivering results impedes the growth of the market over the forecast period of 2021-2027.

Asia Pacific, North America, Europe, Latin America, and the Rest of the World are considered in the geographical overview of the global Zika Virus Testing industry. Due to the pervasive potential of the Zika Virus, Latin America is the world’s leading region in terms of market share. Latin America, on the other hand, is expected to rise at the fastest pace between 2021 and 2027, as Aedes aegypti mosquitoes raise the chances of viral spread in this area, resulting in lucrative growth opportunities for the Zika Virus Testing market in the Asia-Pacific region.

Major market player included in this report are:
EUROIMMUN US Inc.
Creative Diagnostics
Quest Diagnostics
Artron Laboratories Inc.
RapiGEN Inc.
GenBody Inc.
JAJ International Inc.
LumiQuick Diagnostics Inc.
Biocan Diagnostics Inc.
NECTAR LIFESCIENCES LTD.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Test Type:
Rapid IgG/IgM Test
ELISA Test
By End-User:
Hospitals & Clinics
Private Commercial Laboratories
Government/Publicly Funded Programs

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027

Target Audience of the Global Zika Virus Testing Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.



Loading…